Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bluejay Diagnostics (BJDX) Accumulated Expenses (2022 - 2023)

Historic Accumulated Expenses for Bluejay Diagnostics (BJDX) over the last 2 years, with Q2 2023 value amounting to $1.4 million.

  • Bluejay Diagnostics' Accumulated Expenses rose 7771.67% to $1.4 million in Q2 2023 from the same period last year, while for Jun 2023 it was $1.4 million, marking a year-over-year increase of 7771.67%. This contributed to the annual value of $835730.0 for FY2022, which is N/A changed from last year.
  • Bluejay Diagnostics' Accumulated Expenses amounted to $1.4 million in Q2 2023, which was up 7771.67% from $863397.0 recorded in Q1 2023.
  • Bluejay Diagnostics' 5-year Accumulated Expenses high stood at $1.4 million for Q2 2023, and its period low was $592622.0 during Q1 2022.